1. Costs and outcomes of treating chronic hepatitis C patients in routine care – results from a nationwide multicenter trial. Issue 2 (28th September 2015) Authors: Stahmeyer, J. T.; Krauth, C.; Bert, F.; Pfeiffer‐Vornkahl, H.; Alshuth, U.; Hüppe, D.; Mauss, S.; Rossol, S. Journal: Journal of viral hepatitis Issue: Volume 23:Issue 2(2016) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection. Issue 1 (21st June 2013) Authors: Mihm, U.; Welker, M.‐W.; Teuber, G.; Wedemeyer, H.; Berg, T.; Sarrazin, C.; Böhm, S.; Alshuth, U.; Herrmann, E.; Zeuzem, S. Journal: Journal of viral hepatitis Issue: Volume 21:Issue 1(2014) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome. Issue 4 (4th October 2012) Authors: Mauss, S.; Berger, F.; Schober, A.; Moog, G.; Heyne, R.; John, C.; Pape, S.; Hueppe, D.; Pfeiffer‐Vornkahl, H.; Alshuth, U. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 4(2013) Page Start: e72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗